DNA analysis as a tool to confirm the diagnosis of asymptomatic hereditary neuropathy with liability to pressure palsies (HNPP) with further evidence for the occurrence of de novo mutations.
We performed DNA analysis in four families with hereditary neuropathy with liability to pressure palsy (HNPP). An interstitial deletion of the 17 p11.2 region was found in typically affected patients as well as in as yet asymptomatic patients. The opportunity for an individual genotyping permitted to ascertain a de novo deletion in one clinically affected case with no relevant familial history. DNA analysis thus becomes the most sensitive tool in diagnosing HNPP, since potentially affected patients may lack either informative familial history, or clinical symptoms or even suggestive EMG or histopathological data (tomaculas).
Gonnaud
P M
PM
Service d'Explorations Fonctionnelles et Consultations Neurologiques, Centre Hospitalier Lyon-Sud, France.
Sturtz
F
F
Fourbil
Y
Y
Bonnebouche
C
C
Tranchant
C
C
Warter
J M
JM
Chazot
G
G
Bady
B
B
Vial
C
C
Brechard
A S
AS
D000293:Adolescent; D000328:Adult; D000483:Alleles; D002872:Chromosome Deletion; D004247:DNA / Q000032:analysis*; D005260:Female; D005838:Genotype; D015417:Hereditary Sensory and Motor Neuropathy / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology; D006801:Humans; D008475:Median Nerve / Q000503:physiopathology; D008875:Middle Aged; D016296:Mutagenesis; D010543:Peroneal Nerve / Q000503:physiopathology; D017354:Point Mutation; D013979:Tibial Nerve / Q000503:physiopathology; D014459:Ulnar Nerve / Q000503:physiopathology
D004247:DNA